Form D · Biotechnology
Annexon, Inc.
Brisbane, CA · CIK 0001528115
Offering snapshot reported Jul 22, 2022 · SEC filing
- Reported sold
- $130M Offering amount: $130M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 7, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 22, 2022 | Initial | $130,475,296 | No comparison | 12 | SEC filing |
| Jul 16, 2020 | Initial | $101,999,983 | No comparison | 17 | SEC filing |
| Dec 19, 2018 | Initial | $44,999,994 | No comparison | 10 | SEC filing |
| Aug 22, 2011 | Initial | $999,999 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $6.72M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-453365
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | 2347 | |
| Cowen and Company, LLC | 7616 |
Source: Form D, filed Jul 22, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ben Barres | Director |
| William H. Carson, M.D. | Director |
| Jung E. Choi | Director |
| Bettina M. Cockroft, M.D. | Director |
| Emmett Cunningham | Director |
| Carol Gallagher | Director |
| Sanjay Keswani | Executive |
| Jennifer Lew | Executive |
| Douglas Love | Director, Executive |
| Larry C. Mattheakis, Ph.D | Executive |
| Campbell Murray | Director |
| Michael Overdorf | Executive |
| Arnon Rosenthal | Director |
| Muneer A. Satter | Director |
| Mark L Smith | Executive |
| Ricky Sun | Director |
| William D. Waddill | Director |
| Stacie Weninger | Director |
| Thomas G. Wiggans | Director |
| Ted Yednock | Executive |
| William D. Young | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1400 Sierra Point Parkway Bldg C, Suite 200
Brisbane, CA, 94005
Brisbane, CA, 94005